HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 207 filers reported holding HORIZON PHARMA PLC in Q2 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,827,000 | +133.6% | 491,544 | +156.6% | 0.15% | +129.7% |
| Q1 2019 | $5,063,000 | +35.3% | 191,544 | 0.0% | 0.06% | +18.5% |
| Q4 2018 | $3,743,000 | -45.6% | 191,544 | -45.5% | 0.05% | -38.6% |
| Q3 2018 | $6,879,000 | -0.0% | 351,349 | -15.4% | 0.09% | -7.4% |
| Q2 2018 | $6,880,000 | +72.3% | 415,485 | +47.7% | 0.10% | +55.7% |
| Q1 2018 | $3,994,000 | -20.2% | 281,300 | -18.0% | 0.06% | -15.3% |
| Q4 2017 | $5,006,000 | +3.0% | 342,894 | -10.5% | 0.07% | +4.3% |
| Q3 2017 | $4,858,000 | +5.4% | 383,148 | -1.3% | 0.07% | -1.4% |
| Q2 2017 | $4,609,000 | -5.7% | 388,284 | +17.4% | 0.07% | -15.7% |
| Q1 2017 | $4,888,000 | +6.5% | 330,709 | +16.6% | 0.08% | -6.7% |
| Q4 2016 | $4,589,000 | -66.1% | 283,640 | -62.1% | 0.09% | -62.8% |
| Q3 2016 | $13,554,000 | +23.7% | 747,600 | +12.4% | 0.24% | +13.8% |
| Q2 2016 | $10,953,000 | -0.1% | 665,000 | +0.5% | 0.21% | -0.9% |
| Q1 2016 | $10,961,000 | -23.5% | 661,500 | 0.0% | 0.21% | -15.5% |
| Q4 2015 | $14,335,000 | – | 661,500 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |